The effect of transdermal glyceryl trinitrate on 24h ambulatory blood pressure in acute/subacute stroke

International Journal of Stroke

Volumn 6, Issue 4, 2011, Pages 290-294

  Geeganage, Chamila M ^a   Bath, Andrew J G ^a   Bath, Philip M W ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Acute stroke; Blood pressure; Glyceryl trinitrate

Indexed keywords

GLYCERYL TRINITRATE; PLACEBO;

ACUTE DISEASE; AGED; ANTIHYPERTENSIVE ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE MONITORING; BRAIN HEMORRHAGE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; MALE; NITROGLYCERIN; STROKE; TRANSDERMAL PATCH; VASODILATOR AGENTS;

EID: 79960279499     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00566.x     Document Type: Article

References (30)

1. Britton M, Carlsson A, de Faire U. Blood pressure course in patients with acute stroke and matched controls. Stroke 1986; 17:861-4.
2. Oppenheimer S, Hachinski V. Complications of acute stroke. Lancet 1992; 339:721-4.
3. Harper G, Castleden CM, Potter JF. Factors affecting changes in blood pressure after acute stroke. Stroke 1994; 25:1726-9.
4. Wallace JD, Levy LL. Blood pressure after stroke. JAMA 1981; 246:2177-80.
5. Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA, IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002; 33:1315-20.
6. Boreas AM, Lodder J, Kessels F, de Leeuw PW, Troost J. Prognostic value of blood pressure in acute stroke. J Hum Hypertens 2002; 16:111-6.
7. Wityk RJ. The management of blood pressure after stroke. Neurologist 2007; 13:171-81.
8. Jain S, Namboodri KK, Kumari S, Prabhakar S. Loss of circadian rhythm of blood pressure following acute stroke. BMC Neurol 2004; 4:1.
9. Geeganage C, Bath PM. Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev 2008; 8:CD000039.
10. Geeganage CM, Bath PM. Relationship between therapeutic changes in blood pressure and outcomes in acute stroke: a metaregression. Hypertension 2009; 54:775-81.
11. Berge E, Aakvik R, Terent A, Boysen G. Scandinavian Candesartan Acute Stroke Trial (SCAST). Cerebrovasc Dis 2006; 21:124-5.
12. Anderson CS, Huang Y, Wang JG et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008; 7:391-9.
13. ENOS Trial Investigators. Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke 2006; 1:245-9.
14. Bath PM, Pathansali R, Iddenden R, Bath FJ. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc Dis 2001; 11:265-72.
15. Rashid P, Leonardi-Bee J, Weaver C, Bath F, Bath P. The effect of transdermal glyceryl trinitrate on blood pressure and middle cerebral artery velocity in acute stroke. Cerebrovasc Dis 2002; 13 (Suppl. 3): 53 (abstract).
16. Rashid P, Weaver C, Leonardi-Bee JA, Fletcher S, Bath FJ, Bath P. The effects of transdermal glyceryl trinitrate, a nitric oxide donor on blood pressure, cerebral and cardiac haemodynamics and plasma nitric oxide levels in acute stroke. J Stroke Cerebrovasc Dis 2003; 13:143-51.
17. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet 1988 13; 2:397.
18. Omboni S, Parati G, Zanchetti A, Mancia G. Calculation of trough: peak ratio of antihypertensive treatment from ambulatory blood pressure: methodological aspects. J Hypertens 1995; 13:1105-12.
19. Morgan T, Ménard J, Brunner H. Trough to peak ratio as a guide to BP control: measurement and calculation. J Hum Hypertens 1998; 12:49-53.
20. Wolff M, Cordes G, Luckow V. In vitro and in vivo-release of nitroglycerin from a new transdermal therapeutic system. Pharm Res 1985; 1:23-9.
21. Voogel AJ, van der Meulen JH, van Montfrans GA. Effects of antihypertensive drugs on the circadian blood pressure profile. J Cardiovasc Pharmacol 1996; 28:463-9.
22. Gosse P, Neutel JM, Schumacher H, Lacourciére Y, Williams B, Davidai G. The effect of telmisartan and ramipril on early morning blood pressure surge: a pooled analysis of two randomized clinical trials. Blood Press Monit 2007; 12:141-7.
23. Verdecchia P, Schillaci G, Guerrieri M et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81:528-36.
24. Sander D, Klingelhöfer J. Changes of circadian blood pressure patterns after hemodynamic and thromboembolic brain infarction. Stroke 1994; 25:1730-7.
25. Castilla-Guerra L, Fernández-Moreno Mdel C, Espino-Montoro A, López-Chozas JM. Ambulatory blood pressure monitoring in stroke survivors: do we really control our patients? Eur J Intern Med 2009; 20:760-3.
26. Yamamoto Y, Akiguchi I, Oiwa K, Hayashi M, Ohara T, Ozasa K. The relationship between 24-hour blood pressure readings, subcortical ischemic lesions and vascular dementia. Cerebrovasc Dis 2005; 19:302-8.
27. Kukla C, Sander D, Schwarze J, Wittich I, Klingelhöfer J. Changes of circadian blood pressure patterns are associated with the occurrence of lucunar infarction. Arch Neurol 1998; 55:683-8.
28. Prattichizzo FA, Galetta F, Simonetti I. Problems in the evaluation of antihypertensive therapy using the trough/peak ratio. Cardiovasc Drugs Ther 1997; 11:459-63.
29. Wahlgren NG, MacMahon DG, de Keyser J, Indredavik B, Ryman T. Intravenous Nimodipine West European Stroke Trial (INWEST) of Nimodipine in The Treatment of Acute Ischaemic Stroke. Cerebrovasc Dis 1994; 4:204-10.
30. Ahmed N, Näsman P, Wahlgren NG. Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 2000; 31:1250-5.